Melphalan vs polymelphalanum in ovarian cancer patients resistant to cyclophosphamide: A tentative statistical approach to balance risks and benefits
- 1 August 1977
- journal article
- research article
- Published by Elsevier in European Journal of Cancer (1965)
- Vol. 13 (8), 817-820
- https://doi.org/10.1016/0014-2964(77)90136-0
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Continuous low-dose cyclophosphamide (NSC-26271) therapy in advanced ovarian cancerEuropean Journal of Cancer (1965), 1976
- Chemotherapy in the treatment of cancer of the ovaryAmerican Journal of Obstetrics and Gynecology, 1970